Skip to main content

Table 2 Sensitivity, specificity, PPV, NPV, and accuracy of serum FGF19 levels and the existing markers alone and in combination in all the HCC cases

From: Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma

 Sensitivity (%)Specificity (%)PPV (%)NPV (%)Accuracy (%)
Single marker
Double markers
 AFP and DCP73.791.795.361.077.6
 AFP and FGF1976.091.595.164.080.9
 DCP and FGF1981.391.095.468.882.5
Multiple markers
 AFP, DCP, and FGF1987.587.294.076.385.7